YAKHAK HOEJI
ISSN 0377-9556 (PRINT)
ISSN 2383-9457 (ONLINE)
ISSN 2383-9457 (ONLINE)
The number of serious adverse events of baricitinib
| Serious adverse events | |
|---|---|
| number (%) | |
| Respiratory system disorders | 6 (5.3) |
| Pneumonia | 4 (3.5) |
| Pulmonary infiltration | 1 (0.9) |
| Dyspnoea | 1 (0.9) |
| Body as a whole-general disorders | 3 (2.7) |
| Asthenia | 2 (1.8) |
| Condition aggravated | 1 (0.9) |
| Urinary system disorders | 3 (2.7) |
| Pyelonephritis | 3 (2.7) |
| Vascular (extracardiac) disorders | 2 (1.8) |
| Thrombophlebitis deep | 1 (0.9) |
| Cerebral infarction | 1 (0.9) |
| Gastro-intestinal system disorders | 1 (0.9) |
| Nausea | 1 (0.9) |
| Resistance mechanism disorders | 1 (0.9) |
| Sepsis | 1 (0.9) |
| Liver and biliary system disorders | 1 (0.9) |
| Hepatitis | 1 (0.9) |
| Musculo-skeletal system disorders | 1 (0.9) |
| Myositis | 1 (0.9) |
| White cell and RES* disorders | 1 (0.9) |
| Agranulocytosis | 1 (0.9) |
| Myo-, endo-, pericardial & valve disorders | 1 (0.9) |
| Pericarditis | 1 (0.9) |
| Platelet, bleeding & clotting disorders | 1 (0.9) |
| Thrombocytopenia | 1 (0.9) |
*RES: Reticuloendothelial System